The largest database of trusted experimental protocols

6 protocols using jetprime versatile dna sirna transfection reagent

1

Murine and Human LUAD Cell Lines for Cancer Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The murine LUAD cell lines used and their derivations include LKR10 and LKR13 (KrasLA1) (53 (link)); 713P, 307P, 412P, 393LN, 531P1, 531LN1, 344P, 344SQ, 531LN2, 344LN, 531LN3, and 531P2 (KrasG12D; Trp53R172H) (54 (link)); and KC2 and KC4 (KrasG12D; CDKN2A−/−) (55 (link)). Human LUAD cell lines (A549, H1299, H322, H460, H1650, H522, H596, H23, H1792, H441, H358, H157, H226, H2122, CALU-1, CALU-6, H292, and H520) were purchased (American Type Culture Collection). Murine and human LUAD cells were cultured in RPMI 1640 containing 10% fetal bovine serum. Cells were maintained at 37°C in an incubator with a humidified atmosphere containing 5% CO2. Cells were transfected with jetPRIME Versatile DNA/siRNA transfection reagent (Polyplus). Stable cell transfectants were selected using puromycin (for pLVX, pBabe-puro, and pLKO.1 vectors) or G418 (for pcDNA3.1 and pEGFP-C3 vectors). CRISPR-Cas9–mediated p53 KO 344SQ cells were generated in the Cell-Based Assay Screening Service Core Facility (Baylor College of Medicine) using the following guide RNA sequences: 5′-acagccatcacctcactgca (tgg) and 5′-(ccc) agccactccatggcccctgt. CRISPR-Cas9–mediated p53 KO A549 cells were generated as described (13 ).
+ Open protocol
+ Expand
2

Cripto-1 Silencing via siRNA Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small-interfering RNAs (siRNAs) were purchased from Thermo Fisher Scientific. Cells were transfected with siRNA duplexes using the jetPRIME Versatile DNA/siRNA transfection reagent (Polyplus, New York, NY, USA) according to the manufacturer’s instructions. The sense and antisense strands of Cripto-1 siRNA were as follows: si-Cripto1#1: 5′-GGA UCA UGG CCA UUU CUA AAG UCU U-3′ (sense) and 5′-AAG ACU UUA GAA AUG GCC AUG AUC C-3′ (antisense); si-Cripto1#2: 5′-UCA UGC AAA UUU CAU GAC CAG UAA A-3′ (sense) and 5′-UUU ACU GGU CAU GAA AUU UGC AUG A-3′ (antisense); si-Cripto1#3: 5′-GGG CCA UCA GGA AUU UGC UCG UCC A-3′ (sense) and 5′-UGG ACG AGC AAA UUC CUG AUG GCC C-3′ (antisense).
+ Open protocol
+ Expand
3

Recombinant Plasmid Transfection in HEK293T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HEK293T cells were cultured in DMEM supplemented with 10% FBS and seeded into 48-well cell culture plates at a density of 2 × 104 cells/well. They were then incubated overnight at 37°C with 5% CO2. Once the cells reached a confluency of 70–80%, the recombinant plasmid pCAGGS-gE was transfected into the cells using the jetPRIME® Versatile DNA/siRNA transfection reagent (Polyplus, France) and cultured at 37°C for 48 h. After culturing, the plates were fixed with methanol (precooled to −20°C) for 20 min at room temperature (RT). Next, the plates were washed with PBST and incubated with skim milk (5%) at 37°C for 1 h. Then, anti-PRV gE was used as a primary antibody for 30 min, while DMEM served as a negative control. Subsequently, the plates were washed three times with PBST and incubated with anti-mouse IgG H&L (FITC) (Solarbio, Beijing, China) for half an hour at 37°C. Cells were simultaneously stained using DAPI (4′,6-diamidino-2-phenylindole) from Solarbio. After the final washing, fluorescence signals were visualized using fluorescence microscopy from ZEISS in Jena, Germany.
+ Open protocol
+ Expand
4

Derivation of PI4KIIIβ Antagonist-Tolerant Lung Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human lung cancer cell lines H2122 and H3122 and lung epithelial cell line BEAS-2B were cultured in RPMI Media 1640 (Life Technologies, 11875093) containing 10% fetal bovine serum (Thermo Fisher Scientific, SH30071.03). Cells were maintained at 37 °C in an incubator with a humidified atmosphere containing 5% CO2. To derive cells that are tolerant to PI4KIIIβ antagonists, H2122 cells and H3122 cells were treated with Compound B (11 (link)) or IN-9 (MedChemExpress, HY-19798) for 4 wk starting at 0.5 µM. Media containing vehicle or inhibitor were replaced every 2 d. Doses were increased every 6 d to a final dose of 10 µM. After 12 wk of treatment, including 2 wk at the highest dose level, the cells were considered drug tolerant. Cells were transfected with jetPRIME Versatile DNA/siRNA transfection reagent (Polyplus, 114-15).
+ Open protocol
+ Expand
5

Generating Ku70-Deficient Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293 TREx cells (Invitrogen Canada Inc.) were cultured in high-glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37 °C in 5% CO2. to which 1% L-glutamine, and 1% sodium pyruvate were added.
Transfections were performed using jetPRIME Versatile DNA/siRNA transfection reagent, following the manufacturer’s instructions (Polyplus Transfection Inc). Antibiotic was added 24–48 h after transfection for selection. Single clones that grew in the presence of antibiotic were moved to 96 well plates and then grown until they could be moved to 6-well plates. Clones were assessed by western blot for a reduction in Ku70 protein following Dox withdrawal for at least 7 days.
Ku70-/- cell lines were maintained with 1 μg/mL Doxycycline (BioShop Canada Inc.) administered every 48 h, and 15 μg/mL Blasticidin (MULTICELL), and 15 μg/mL Hygromycin (MULTICELL) which were administered every 96 h.
+ Open protocol
+ Expand
6

Lung Cancer Cell Lines and HUVEC Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human lung cancer cell lines (A549, H1299, H157, CALU-1, CALU-6, H322, H441, H358, HCC827, H522, H2122, H23, H1792, H441, H358, H226, and H1395) and HUVECs were purchased from the American Type Culture Collection (ATCC). HCC827-Vec and HCC827-ZEB1 cells and the murine LUAD cell line 344SQ were previously described (19 (link)). Lung cancer cells were cultured in RPMI 1640 containing 10% FBS. HUVECs were cultured in EGM-2 Endothelial Cell Growth Medium (Lonza). Cells were maintained at 37°C in an incubator with a humidified atmosphere containing 5% CO2. Cells were transfected with jetPRIME Versatile DNA/siRNA transfection reagent (Polyplus). Stable cell transfectants were selected using puromycin (for pLVX and pLKO.1 vectors) or G418 (for pcDNA3.1 and pEGFP-C3 vectors). PI4K2A-KO H1299 cells were generated using the CRISPR/Cas9 system in the Cell-Based Assay Screening Service Core Facility at Baylor College of Medicine (guide RNA sequences: 5′-CCCACTAGTGTCCCCCGAGC-3′ and 5′-TTTCCCGAGCGCATCTACCA-3′).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!